期刊文献+

紫外分光光度法体外筛选5α-还原酶抑制药 被引量:2

UV-spectrophotometric Screening of 5α-Reductase Inhibitors in vitro
暂未订购
导出
摘要 目的:从天然产物中筛选5α-还原酶抑制药用于前列腺增生(BPH)的治疗。方法:从SD雄性大鼠前列腺组织中提取5α-还原酶,以睾酮为底物,加入还原型辅酶Ⅱ(NADPH),加入天然产物提取物建立酶反应体系,在37℃连续孵育,采用分光光度法在340 nm波长处检测辅酶NADPH 10 min内吸光度值变化,以前列康醇提物和生理盐水分别为阳性对照和阴性对照,筛选5α-还原酶抑制药,并对其活性成分进行初步确定。结果:8种天然产物中,槟榔、地榆提取物对5α-还原酶有一定抑制作用,且地榆醇提液,槟榔水提液和醇提液酶抑制活性较强。结论:紫外分光光度法操作简单、经济可行,适用于5α-还原酶抑制药的初步筛选。 Objective: To screen 5α-reductase inhibitors from the natural products for the treatment of benign prostatic hyperplasia (BPH). Method: Testosterone as the substrate and NADPH as the hydrogen donor,5α-reduetase extracted from the prostate tissue of male rats was added into the extracts of natural products to establish the enzyme reaction system by continuous incubation at 37℃. The change of enzymatic activity was recorded by the detection of NADPH with UV-spectrophotometry at the wavelength of 340 nm. Conprata pulean and physiological saline was chosen as the positive control and negative control, respectively for the screen of the 5α-reduetase. The obtained active ingredients were preliminarily identified by a spectrophotometer. Result: Among the 8 kinds of natural products, areca and sanguisorbae showed inhibition against 5α-reduetase. Conclusion: The economical, simple and quick method can be used to screen 5α-reduetase inhibitors.
出处 《中国药师》 CAS 2011年第12期1714-1716,共3页 China Pharmacist
关键词 5α-还原酶抑制药 紫外-可见分光光度法 还原型辅酶Ⅱ 天然产物 5α-Reductase inhibitors UV-visible speetrophotometry NADPH Natural products
  • 相关文献

参考文献9

二级参考文献41

  • 1况刚,邹文俊,高小平.一种非同位素5α-还原酶抑制剂体外筛选模型的建立和应用[J].中药药理与临床,2005,21(4):61-64. 被引量:9
  • 2Vilchis F,Mendez JP,Canto P,et al.Identification of missense mutations in the SRD5A2 gene from patientswith steroid 5 alpha—reductase 2 deficiency[J].Clin Endocrinol(Oxf),2000,52(3):383—387.
  • 3Bird J,Li X,Lei ZM,et al.Luteinizing hormone and human chorionic gonadotropin decrease type 25 alphareductase and androgen receptor protein levels inwomen’S skin [J].J Clin Endocrinol Metab,1998,83(5):1776—1782.
  • 4Silver RI,Russell DW.5 alpha—reductase type 2 mutations are present in some boys with isolated hypospa—dias[J].J Urol,1999,162[3 Pt2]:1142—1145.
  • 5Poletti A,Martini L.Androgen—activating enzymes in the central nervous system[J].J Steroid Biochem Mol Biol,1999,69(1—6):117—122.
  • 6Poletti A,Negri—Cesi P,Rabuffetti M,et al.Transient expression of the 5 alpha—reductase type 2 isozyme in the rat brain in late fetal and early postnatallife[J].Endocrinology,1998,139(4):2171—2178.
  • 7Stoffel WB,Beyenburg S,Watzka M,et al.Expression of 5 alpha—reductase and 3 alpha—hydroxisteroid oxidoreductase in the hippocampus of patients with chronic temporal lobe epilepsy[J].Epilepsia,2000,41(2):140-147.
  • 8Santner SJ,Albertson B,Zhang GY,et al.Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects[J].J Clin Endocrinol Metab,1998,83(6):2104—2109.
  • 9Anderson RA,Kelly RW,Wu FCW.Comparison between testosterone enanthate—induced azoospermia and oligozoospermia in a male contraceptive study.V Localization of higher 5 alpha—reductase activity to the reproductive tract in oligozoospermic men administered supraphysiological doses of testosterone[J].J Andrology,1997,18(4):366—371.
  • 10Parte PP,Balasinor N,Gill—Sharma MK,et al.Effectof 5 alpha—dihydrotestosterone implants on the fertility of male rats treated with tamoxifen[J].J Andrology,2000,21(4):525—533.

共引文献26

同被引文献13

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部